GlassScriptPhysician profile
Maurice Nahabedian
NPI 1265418990
$827,514.86
in general payments reported to CMS, 2019-2025
30 companies · $145K in 2025
The $145K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265K · 2020: $78K · 2021: $93K · 2022: $68K · 2023: $90K · 2024: $88K · 2025: $145K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $191K · Consulting Fee: $62K · Honoraria: $43K · Travel and Lodging: $19K · Food and Beverage: $8,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $191,137.25 |
| Consulting Fee | $61,938.75 |
| Honoraria | $42,500.00 |
| Travel and Lodging | $19,484.69 |
| Food and Beverage | $8,253.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $425,914.25 | 2019-2022 | |
| Abbvie INC. | $257,107.18 | 2022-2025 | |
| Stryker Corporation | $59,565.25 | 2019-2023 | Spy-Phi System, 1688, 1788 |
| Davol INC. | $45,316.90 | 2021-2025 | Phasix Mesh, Arista |
| Polarityte, INC. | $32,850.00 | 2019 | |
| Merz North America, INC. | $1,268.50 | 2023-2025 | Xeomin |
| Integra Lifesciences Corporation | $625.54 | 2019-2025 | Tenoglide, Integra, Surgimend |
| Motiva USA, LLC | $578.69 | 2024-2025 | |
| Smith+Nephew, INC. | $556.53 | 2019-2023 | Grafix |
| Mentor Worldwide LLC | $423.61 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Axogen | $409.56 | 2019-2025 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Vascular Technology, INC. | $400.00 | 2019 | |
| Sientra, INC. | $367.77 | 2019-2020 | |
| Medtronic, INC. | $328.11 | 2022-2024 | Ligasure, Progrip |
| Innovation Technologies INC | $271.55 | 2020-2023 | Irrisept |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $238.15 | 2021 | |
| Myriad Genetic Laboratories, INC. | $221.04 | 2024 | Myrisk |
| Access Pro Medical, LLC | $190.91 | 2025 | Matriderm |
| Rti Surgical, INC | $176.62 | 2025 | |
| Becton, Dickinson and Company | $146.45 | 2025 | Phasix Mesh |
| Baxter Healthcare | $133.04 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $124.64 | 2019 | |
| Avita Medical Americas, LLC | $118.10 | 2024 | |
| Derma Sciences, INC. | $43.41 | 2019 | |
| Tepha INC | $39.34 | 2019 | |
| W. L. Gore & Associates, INC. | $34.56 | 2019 | |
| Coopersurgical, INC. | $19.57 | 2020 | |
| Kci USA, INC. | $18.12 | 2020 | |
| Acell, INC. | $14.98 | 2020 | |
| Tela Bio, INC. | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Nahabedian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.